R. Levitzki

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.

B. Klein, N. Rojansky, N. Laufer, 2004, Human reproduction.

Tyrosine Kinase Inhibitors Suppress the Growth of Non-Hodgkin B Lymphomas

A. Levitzki, A. Gazit, B. Klein, 2002, Journal of Pharmacology and Experimental Therapeutics.

Changes of PI3K/AKT/BCL2 signaling proteins in congenital Giant Nevi: melanocytes contribute to their increased survival and integrity

A. Margulis, L. Drukker, M. Chaouat, 2013, Journal of receptor and signal transduction research.

All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas.

B. Klein, N. Rojansky, A. Shushan, 2011, Fertility and sterility.

Targeting leiomyomas with all‐trans‐retinoic acid at phosphoinositide 3‐kinase pathway suppression: Effective roles of β‐catenin and of signaling interactions

N. Rojansky, A. Shushan, D. Shveiky, 2016, The journal of obstetrics and gynaecology research.

Inhibitors that target protein kinases for the treatment of ovarian carcinoma.

B. Klein, N. Rojansky, N. Laufer, 2003, American journal of obstetrics and gynecology.

Src protein and tyrosine‐phosphorylated protein profiles in marrow stroma during osteogenic stimulation

B. Klein, H. Ben-bassat, R. Levitzki, 1998, Journal of cellular biochemistry.

Changes related to phosphatidylinositol 3-kinase/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology.

B. Klein, N. Rojansky, A. Shushan, 2010, Fertility and sterility.